MARKET

HOTH

HOTH

Hoth Therapeutics
NASDAQ

Real-time Quotes | Nasdaq Last Sale

2.310
-0.040
-1.70%
Pre Market: 2.400 +0.09 +3.90% 06:27 03/02 EST
OPEN
2.350
PREV CLOSE
2.350
HIGH
2.468
LOW
2.220
VOLUME
92
TURNOVER
--
52 WEEK HIGH
7.00
52 WEEK LOW
1.560
MARKET CAP
31.04M
P/E (TTM)
-2.4976
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
Hoth Therapeutics completes site recruitment for atopic dermatitis study cohort 1
Hoth Therapeutics ([[HOTH]] +0.9%) announces that it has completed recruitment of cohort 1 for its upcoming first in human clinical trial of the proprietary BioLexa platform to treat atopic dermatitis,
Seekingalpha · 15h ago
Hoth Therapeutics Completes Site Recruitment for Cohort 1 of First in Human Clinical Trial of BioLexa for the Treatment of Atopic Dermatitis
, /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a , is pleased to announce it has completed recruitment of Cohort 1 for its upcoming first in human clinical trial of the proprietary BioLexa platform to treat atopic dermatitis, also known as .
PR Newswire - PRF · 15h ago
Hoth Therapeutics expands license agreement to include innovative cancer treatment
Hoth Therapeutics (HOTH) expands its licensing agreement from North Carolina State University to include the worldwide development and commercialization of treatments targeting mast cell derived cancers and anaphylaxis. The HT-KIT drug is designed
Seekingalpha · 3d ago
Hoth Therapeutics Expands License Agreement to Include Innovative Cancer and Anaphylactic Treatment
, /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a , today announced it has expanded its licensing agreement from ("") to include the worldwide development and commercialization of treatments targeting mast cell derived cancers and anaphylaxis. 
PR Newswire - PRF · 3d ago
Hoth Therapeutics Expands Agreement With North Carolina State University to Develop Therapy For Certain Cancers
MT Newswires · 4d ago
Hoth Therapeutics Retains RedChip to Increase Investor Awareness
PR Newswire · 4d ago
DJ Hoth Therapeutics Shares Up After Filing Patent Application for Alzheimer's Treatment
Dow Jones · 5d ago
Hoth Therapeutics expands IP portfolio with novel Alzheimer's disease treatment
Hoth Therapeutics ([[HOTH]] +16.2%) has filed a provisional patent application with the United States Patent and Trademark Office for the use of one of its current portfolio therapeutics to treat and prevent Alzheimer's
Seekingalpha · 5d ago
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of HOTH. Analyze the recent business situations of Hoth Therapeutics through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 1 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average HOTH stock price target is 10.00 with a high estimate of 10.00 and a low estimate of 10.00.
EPS
Institutional Holdings
Institutions: 37
Institutional Holdings: 357.80K
% Owned: 2.66%
Shares Outstanding: 13.44M
TypeInstitutionsShares
Increased
3
86.16K
New
10
67.84K
Decreased
1
6.58K
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
No Data
  • Dividends
  • Splits
  • Insider Activity
No Data
  • All
  • Financials
  • Insiders
More
About HOTH
Hoth Therapeutics, Inc. is a development stage biopharmaceutical company focused on targeted therapeutics for patients suffering from conditions such as atopic dermatitis, also known as eczema. The Company is engaged in developing and commercializing the BioLexa Platform. BioLexa Platform is a proprietary, patented antimicrobial therapy. The BioLexa Platform traps all the zinc ions by adding a chelator called DTPA, which prevents Staph biofilm formation. It intends to explore the use of the BioLexa Platform for the treatment of atopic dermatitis, or eczema. It also focuses on exploring the use of the BioLexa Platform in the aesthetic dermatology field to help treat and reduce post-procedure infections, accelerate healing and improve clinical outcomes for patients undergoing procedures.

Webull offers kinds of Hoth Therapeutics Inc stock information, including NASDAQ:HOTH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, HOTH stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading HOTH stock methods without spending real money on the virtual paper trading platform.